Roth MKM Keeps Their Buy Rating on Constellation Brands (STZ)
Roth MKM analyst Bill Kirk reiterated a Buy rating on Constellation Brands (STZ – Research Report) today and set a price target of $284.00. The ...
Roth MKM Gives a Buy Rating to High Tide (HITI)
Roth MKM analyst Bill Kirk assigned a Buy rating to High Tide (HITI – Research Report) today and set a price target of $4.50. The company’s ...
Fintel on MSN5d
Roth MKM Initiates Coverage of Cingulate (CING) with Buy Recommendation
Fintel reports that on January 10, 2025, Roth MKM initiated coverage of Cingulate (NasdaqCM:CING) with a Buy recommendation.
Hosted on MSN5d
Roth MKM Initiates Coverage of Verona Pharma plc - Depositary Receipt () (VRNA) with Buy Recommendation
Fintel reports that on January 10, 2025, Roth MKM initiated coverage of Verona Pharma plc - Depositary Receipt () ...
bovnews16h
The BE Stock Mystery: Why Did BE Plunge Today?
Bloom Energy Corp (BE) stock saw a decline, ending the day at $22.3 which represents a decrease of $-0.73 or -3.17% from the prior close of $23.03. The stock opened at $23.69 and touched a low of $22.
bovnews15h
Reviva Pharmaceuticals Holdings Inc (RVPH) Stock: More Robust Than the Numbers Suggest?
In recent trading, Reviva Pharmaceuticals Holdings Inc (RVPH) stock price has shown some volatility, fluctuating -19.80% over the last ...
Roth Mkm Initiates Coverage on Reviva Pharmaceuticals (NASDAQ:RVPH)
Roth Mkm started coverage on shares of Reviva Pharmaceuticals (NASDAQ:RVPH – Free Report) in a report released on Friday,Benzinga reports. The brokerage issued a buy rating and a $7.00 price target on ...
Roth Mkm Begins Coverage on Verona Pharma (NASDAQ:VRNA)
Roth Mkm started coverage on shares of Verona Pharma (NASDAQ:VRNA – Free Report) in a report released on Friday morning, MarketBeat.com reports. The firm issued a buy rating and a $68.00 price ...
Nasdaq24d
Roth MKM Initiates Coverage of Reviva Pharmaceuticals Holdings (RVPH) with Buy Recommendation
Fintel reports that on January 10, 2025, Roth MKM initiated coverage of Reviva Pharmaceuticals Holdings (NasdaqCM:RVPH) with a Buy recommendation. As of December 23, 2024, the average one-year ...
Nasdaq24d
Roth MKM Initiates Coverage of Verona Pharma plc - Depositary Receipt () (VRNA) with Buy Recommendation
Fintel reports that on January 10, 2025, Roth MKM initiated coverage of Verona Pharma plc - Depositary Receipt () (NasdaqGM:VRNA) with a Buy recommendation. As of December 23, 2024, the average ...
Investing5d
Roth/MKM initiates coverage on Verona Pharma stock with Buy rating and strong upside potential
Friday - Shares of Verona Pharma (NASDAQ:VRNA) received a positive outlook from Roth/MKM as the firm initiated coverage with a Buy rating and a 12-month price target of $68. The bullish stance is ...
Investing9d
Brazil Potash stock: Roth/MKM sees upside in Autazes project potential
On Tuesday, Roth/MKM initiated coverage on Brazil Potash Corp (NYSE:GRO) stock with a Buy rating and established a price target of $17.00, representing significant upside from the current stock ...